Checkpoint Capital
Latest statistics and disclosures from Checkpoint Capital's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0001977548
Tip: Access up to 7 years of quarterly data
Positions held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Checkpoint Capital
Checkpoint Capital holds 18 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals (RYTM) | 20.3 | $34M | 730k | 45.97 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 16.1 | $27M | 70k | 380.43 |
|
|
| Cytokinetics Com New (CYTK) | 11.6 | $19M | 230k | 83.49 |
|
|
| Spdr Biotech Etf Tr Unit Put Option (XBI) | 9.7 | $16M | 180k | 89.29 |
|
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 9.6 | $16M | 1.4M | 11.44 |
|
|
| Springworks Therapeutics (SWTX) | 7.5 | $12M | 340k | 36.50 |
|
|
| Axsome Therapeutics (AXSM) | 7.5 | $12M | 155k | 79.59 |
|
|
| Mirum Pharmaceuticals (MIRM) | 4.2 | $6.9M | 234k | 29.52 |
|
|
| Protagonist Therapeutics (PTGX) | 3.7 | $6.1M | 267k | 22.93 |
|
|
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 2.8 | $4.6M | 325k | 14.12 |
|
|
| Phathom Pharmaceuticals (PHAT) | 2.0 | $3.3M | 359k | 9.13 |
|
|
| Atyr Pharma Com New (LIFE) | 1.3 | $2.1M | 1.5M | 1.41 |
|
|
| Trevi Therapeutics (TRVI) | 1.0 | $1.7M | 1.3M | 1.34 |
|
|
| Gh Research Ordinary Shares (GHRS) | 1.0 | $1.7M | 294k | 5.80 |
|
|
| Allakos (ALLK) | 0.7 | $1.2M | 445k | 2.73 |
|
|
| Disc Medicine (IRON) | 0.3 | $578k | 10k | 57.76 |
|
|
| Aclaris Therapeutics (ACRS) | 0.3 | $476k | 454k | 1.05 |
|
|
| Edgewise Therapeutics (EWTX) | 0.2 | $361k | 33k | 10.94 |
|
Past Filings by Checkpoint Capital
SEC 13F filings are viewable for Checkpoint Capital going back to 2023
- Checkpoint Capital 2023 Q4 filed Feb. 14, 2024